Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 06AITTAIPEI1730, BNHI DECLINES TO DELAY PHARMACEUTICAL PRICE CUTS

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #06AITTAIPEI1730.
Reference ID Created Released Classification Origin
06AITTAIPEI1730 2006-05-19 10:55 2011-08-23 00:00 UNCLASSIFIED American Institute Taiwan, Taipei
VZCZCXYZ0016
PP RUEHWEB

DE RUEHIN #1730/01 1391055
ZNR UUUUU ZZH
P 191055Z MAY 06
FM AIT TAIPEI
TO RUEHC/SECSTATE WASHDC PRIORITY 0270
INFO RUEHBJ/AMEMBASSY BEIJING 5223
RUEHHK/AMCONSUL HONG KONG 6432
UNCLAS AIT TAIPEI 001730 
 
SIPDIS 
 
STATE PLEASE PASS TO AIT/W AND EAP/RSP/TC 
 
STATE PASS USTR/WINELAND 
 
USDOC FOR 4430/ITA/MAC/MBMORGAN 
 
 
 
SIPDIS 
 
E.O. 12958: N/A 
TAGS: ETRD ECON TW
SUBJECT:  BNHI DECLINES TO DELAY PHARMACEUTICAL PRICE CUTS 
 
REF:  A) TAIPEI 1289, B) 05 TAIPEI 4685 
 
1.  Summary.  AmCham Pharmaceutical Committee members and AIT/T met 
with Bureau of National Health Insurance (BNHI) officials on May 15, 
2006 as part of regular bimonthly consultations between U.S. 
industry and BNHI.  AmCham members shared points that will be raised 
in its soon to be released White Paper.  AIT/T listed concerns to be 
raised in the May 25-26 Trade and Investment Framework Agreement 
(TIFA) consultations. AIT/T proposed that BNHI postpone impending 
reimbursement price cuts, but BNHI President Liu Chien-hsian 
declined to do so, citing pressure from the Legislature to reduce 
expenditures.   End Summary. 
 
AmCham White Papers on Pharmaceutical Issues 
-------------------------------------------- 
 
2.  Melt Van Der Spuy, Chairman of AmCham Pharmaceutical Committee, 
opened the meeting by praising BNHI's success in reducing outpatient 
visits to medical research centers by introducing a co-payment 
mechanism, adjusting premiums based on household income, providing 
data exclusivity protection for patented drugs, and readjusting 
reimbursement pricing of generics to 80 percent of originals.  This 
last measure would weaken generics' ability to offer discounts to 
hospitals and thus partially address the "black hole" problem. 
However, U.S. pharmaceutical industry representatives continued to 
express their concerns over the high number of outpatient visits and 
improper over-prescription of drugs. AmCham members urged BNHI to 
consider further reducing the reimbursement price of generics to 70% 
of that of innovative drugs.  Finally, the U.S. pharmaceutical 
industry encouraged Taiwan to implement actual transaction pricing 
(ATP) and to separate prescribing and dispensing (SPD). 
 
TIFA Theme I -- Price Volume Survey (PVS) 
----------------------------------------- 
 
3.  U.S. pharmaceutical companies questioned the accuracy of the 
price volume survey information collected by BNHI.  Firms noted that 
the local press reports cases of drug wholesales filling false 
pricing information with BNHI.  According to the reports,  Taiwan 
authorities have begun investigating 9,800 local drug wholesalers, 
accounting for nearly 45 percent of pharmaceutical firms in Taiwan, 
for filing false information in order to get a higher reimbursement 
price. 
 
4.  U.S. industry also asked BNHI to adopt a more transparent and 
predictable pricing mechanism in order to create a workable 
operational market environment for U.S. firms.  Industry asked BNHI 
to suspend the PVS and subsequent reimbursement price cuts pending 
completion of the investigations and creation of a more transparent 
survey system.  BNHI President Liu responded that BNHI is obligated 
to follow established legal procedures, and cannot suspend the price 
volume survey.  Liu suggested that BNHI was willing to consider any 
proposals from industry that would improve implementation of the 
PVS, but repeated that BNHI could not suspend or postpone the 
planned price cuts. 
 
TIFA Theme II -- Universal Price Cuts 
------------------------------------- 
 
5.  BNHI Vice President Lee Cheng-hwa asked what U.S. firms would 
think of a universal price cut.  U.S. industry representatives 
responded that such a proposal could be considered but would require 
additional specifics to ensure that generic drug reimbursements are 
subject to deeper cuts. 
 
 
TIFA Theme IV -- Official Notification of IPR Infringement 
--------------------------------------------- 
 
6.  U.S. industry representatives and AIT asked BNHI to support 
plans to protect patented drugs from infringing generics by 
establishing a patent linkage system modeled on the U.S. system. 
BNHI Chairman Liu responded that IPR concerns were best handled by 
the Department of Health, but promised to pass the concern to DOH. 
Liu noted that current regulations require BNHI to approve 
reimbursement prices for DOH-approved generics without consideration 
of patent infringement. 
 
Need additional Pressure to Move BNHI on PVS Price Cuts 
--------------------------------------------- ----- 
 
7.  Comment:  AIT/T has successfully assisted U.S. pharmaceutical 
industry to establish a regular communication channel with Taiwan's 
health care administration offices.  This has been a useful tool to 
improve communication between the Taiwan authorities and 
international industry and minimize misunderstandings.  The TIFA 
meetings May 25 and 26 are another opportunity to press the Taiwan 
authorities to deliver concrete results to meet industry concerns 
about pharmaceutical pricing.  BNHI Chairman Liu is feeling pressure 
from Taiwan's legislature to cut costs; he was insistent that the 
PVS price cut would take effect in July as planned.  End Comment. 
 
YOUNG